SaaS startups have become the darling of Venture Capital investors, especially in the Life Science industry. Over the past decade, software has proverbially “eaten the world” and SaaS companies have scaled to become unicorn corporations in staggering amounts of time.
In this article, we are examining 2 VC funded SaaS startups in the Life Science industry.
Pluto is a B2B SaaS platform that empowers researchers to explore their data and make high-quality, meaningful discoveries in a fraction of the time. For biology labs, Pluto is the single source of truth, a secure home for organizing all of their experimental data, analysis, and figures. Researchers can upload data and run statistics- and machine learning-based analyses easily in their browser, with no coding required. Unique share links enable private sharing between collaborators, as well as public sharing of Pluto Projects to support full reproducibility of scientific manuscripts. The Pluto platform also allows researchers to compare their own results against a database of thousands of published experiments, bringing the global scientific community closer so that more life-changing discoveries can reach the world.
Triall brings Web3 to medical research by creating a digital ecosystem of blockchain-integrated software solutions that secure and streamline clinical trials. Triall’s solutions make clinical trials tamper-resistant and enable secure and efficient integrations between the many isolated systems and parties involved in clinical trial processes. Triall’s software is co-created with clinical trial professionals to ensure optimal user experience, solving actual industry pain points.